Impact of anemia on platelet response to clopidogrel in patients undergoing percutaneous coronary stenting

American Journal of Cardiology

Volumn 109, Issue 8, 2012, Pages 1148-1153

  Toma, Catalin ^a   Zahr, Firas ^a   Moguilanski, Diego ^a   Grate, Sheree ^a   Semaan, Roy W ^a   Lemieux, Nicole ^a   Lee, Joon S ^a   Cortese Hassett, Andrea ^b   Mulukutla, Suresh ^a   Rao, Sunil V ^c   Marroquin, Oscar C ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Institute for Transfusion Medicine (ItXM)   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; COHORT ANALYSIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIGH RESIDUAL PLATELET REACTIVITY; HUMAN; LOADING DRUG DOSE; LONGITUDINAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADENOSINE DIPHOSPHATE; AGED; ANEMIA; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; REGISTRIES; STENTS; TICLOPIDINE;

EID: 84862829083     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.11.049     Document Type: Article

References (21)

1. D. Erlinge, C. Varenhorst, O.O. Braun, S. James, K.J. Winters, J.A. Jakubowski, J.T. Brandt, A. Sugidachi, A. Siegbahn, L. Wallentin Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo J Am Coll Cardiol 52 2008 1968 1977
2. J.M. Sweeny, D.A. Gorog, V. Fuster Antiplatelet drug " resistance" Part 1. Mechanisms and clinical measurements Nat Rev Cardiol 6 2009 273 282
3. R. Marcucci, A.M. Gori, R. Paniccia, B. Giusti, S. Valente, C. Giglioli, P. Buonamici, D. Antoniucci, R. Abbate, G.F. Gensini Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up Circulation 119 2009 237 242
4. N.J. Breet, J.W. van Werkum, H.J. Bouman, J.C. Kelder, H.J. Ruven, E.T. Bal, V.H. Deneer, A.M. Harmsze, J.A. van der Heyden, B.J. Rensing, M.J. Suttorp, C.M. Hackeng, J.M. ten Berg Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
5. M.J. Price, S. Endemann, R.R. Gollapudi, R. Valencia, C.T. Stinis, J.P. Levisay, A. Ernst, N.S. Sawhney, R.A. Schatz, P.S. Teirstein Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000 (Pubitemid 351844676)
6. M.J. Price, P.B. Berger, P.S. Teirstein, J.F. Tanguay, D.J. Angiolillo, D. Spriggs, S. Puri, M. Robbins, K.N. Garratt, O.F. Bertrand, M.E. Stillabower, J.R. Aragon, D.E. Kandzari, C.T. Stinis, M.S. Lee, S.V. Manoukian, C.P. Cannon, N.J. Schork, E.J. Topol GRAVITAS Investigators Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the gravitas randomized trial JAMA 305 2011 1097 1105
7. G. Campo, G. Parrinello, P. Ferraresi, B. Lunghi, M. Tebaldi, M. Miccoli, J. Marchesini, F. Bernardi, R. Ferrari, M. Valgimigli Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome J Am Coll Cardiol 57 2011 2474 2483
8. L. Bonello, U.S. Tantry, R. Marcucci, R. Blindt, D.J. Angiolillo, R. Becker, D.L. Bhatt, M. Cattaneo, J.P. Collet, T. Cuisset, C. Gachet, G. Montalescot, L.K. Jennings, D. Kereiakes, D. Sibbing, D. Trenk, J.W. Van Werkum, F. Paganelli, M.J. Price, R. Waksman, P.A. Gurbel Working Group on High On-Treatment Platelet Reactivity Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
9. M.J. Price, K.R. Nayak, C.M. Barker, D.E. Kandzari, P.S. Teirstein Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention Am J Cardiol 103 2009 1339 1343
10. E.H. Elsenberg, J.W. van Werkum, R.M. van de Wal, A.C. Zomer, H.J. Bouman, F.W. Verheugt, J.M. Berg, C.M. Hackeng The influence of clinical characteristics, laboratory and inflammatory markers on "high on-treatment platelet reactivity" as measured with different platelet function tests Thromb Haemost 102 2009 719 727
11. S. Voisin, V. Bongard, M.A. Tidjane, T. Lhermusier, D. Carrié, P. Sié Are P2Y12 reaction unit (PRU) and % inhibition index equivalent for the expression of P2Y12 inhibition by the VerifyNow assay? Role of haematocrit and haemoglobin levels Thromb Haemost 106 2011 227 229
12. E. Cecchi, R. Marcucci, R. Paniccia, B. Bandinelli, S. Valente, C. Giglioli, C. Lazzeri, G.F. Gensini, R. Abbate, L. Mannini Effect of blood hematocrit and erythrocyte deformability on adenosine 5′-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy Am J Cardiol 104 2009 764 768
13. D.N. Bell, S. Spain, H.L. Goldsmith Extracellular-free Ca++ accounts for the sex difference in the aggregation of human platelets in citrated platelet-rich plasma Thromb Res 58 1990 47 60 (Pubitemid 20146923)
14. R.M. Hardisty, R.A. Hutton, D. Montgomery, S. Rickard, H. Trebilcock Secondary platelet aggregation: a quantitative study Br J Haematol 19 1970 307 319
15. G.L. Dale, L. Alberio Is there a correlation between raised erythropoietin and thrombotic events in sickle-cell anaemia? Lancet 352 1998 566 567 (Pubitemid 28372238)
16. D. Tssies, J.C. Reverter, A. Cases, J. Calls, G. Escolar, A. Ordinas Effect of recombinant human erythropoietin treatment on circulating reticulated platelets in uremic patients: association with early improvement in platelet function Am J Hematol 59 1998 105 109 (Pubitemid 28443235)
17. S.V. Manoukian, F. Feit, R. Mehran, M.D. Voeltz, R. Ebrahimi, M. Hamon, G.D. Dangas, A.M. Lincoff, H.D. White, J.W. Moses, S.B. King III, E.M. Ohman, G.W. Stone Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the acuity trial J Am Coll Cardiol 49 2007 1362 1368 (Pubitemid 46476844)
18. K. Tsujita, E. Nikolsky, A.J. Lansky, G. Dangas, M. Fahy, B.R. Brodie, D. Dudek, M. Mckel, A. Ochala, R. Mehran, G.W. Stone Impact of anemia on clinical outcomes of patients with st-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial) Am J Cardiol 105 2010 1385 1394
19. S. Sattur, K.J. Harjai, A. Narula, S. Devarakonda, P. Orshaw, K. Yaeger The influence of anemia after percutaneous coronary intervention on clinical outcomes Clin Cardiol 32 2009 373 379
20. G. Greenberg, A. Assali, H. Vaknin-Assa, D. Brosh, I. Teplitsky, S. Fuchs, A. Battler, R. Kornowski, E.I. Lev Hematocrit level as a marker of outcome in st-segment elevation myocardial infarction Am J Cardiol 105 2010 435 440
21. P.A. Aarts, R.M. Heethaar, J.J. Sixma Red blood cell deformability influences plateletsvessel wall interaction in flowing blood Blood 64 1984 1228 1233 (Pubitemid 15224534)